The Study Effectiveness of Mindfulness integrated Cognitive Behavior Group Therapy on patients with Multiple Sclerosis

The Study Effectiveness of Mindfulness integrated Cognitive Behavior Group Therapy on psychological symptoms in patients with Multiple Sclerosis

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20160103025817N4

Enrollment

Registered

2018-03-17

Start date

2018-03-21

Completion date

Unknown

Last updated

2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis. Nodular sclerosis classical Hodgkin lymphoma, lymph nodes of multiple sites

Interventions

Intervention group: For eight consecutive two-hour sessions, Mindfulness integrated Cognitive Behavior Group Therapy ..

Eligibility

Sex/Gender

All

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Incidence of recurrent MS-type MS with diagnosis of neurologist Confirmation of MS disease based on the results of diagnostic procedures (such as cerebrospinal fluid test, magnetic resonance imaging, MRI) Awareness of patients from MS in the last year The age range is between 50 to 18 years old Conscious and written consent for participation in the research Having at least a cycle education to complete questionnaires

Exclusion criteria

Exclusion criteria: affected by other physical illnesses affected by Psychosis and delusional states Existence of severe arousal (such as extreme anxiety or anger, impulsivity or uncontrollable restlessness) Patients who use psychotherapy during research.

Design outcomes

Primary

Measure	Time frame
Depression. Timepoint: First study?after the study?Follow up. Method of measurement: Beck Depression Inventory.;Anxiety. Timepoint: First study, after the study, follow up. Method of measurement: Beck Anxiety Inventory.;Sleep quality. Timepoint: First study, after study, follow up. Method of measurement: Pittsburgh Sleep Quality Index.;Fatigue. Timepoint: First study, after study, follow up. Method of measurement: Fatigue Severity Scale.;Life expectancy. Timepoint: First study, after study, follow up. Method of measurement: Miller Life expectancy questionnaire.	—

Measure

Time frame

Depression. Timepoint: First study?after the study?Follow up. Method of measurement: Beck Depression Inventory.;Anxiety. Timepoint: First study, after the study, follow up. Method of measurement: Beck Anxiety Inventory.;Sleep quality. Timepoint: First study, after study, follow up. Method of measurement: Pittsburgh Sleep Quality Index.;Fatigue. Timepoint: First study, after study, follow up. Method of measurement: Fatigue Severity Scale.;Life expectancy. Timepoint: First study, after study, follow up. Method of measurement: Miller Life expectancy questionnaire.

—

Secondary

Measure	Time frame
Quality of Life Score. Timepoint: First study, after study, follow up. Method of measurement: Beck Depression Inventory.;Life expectancy score. Timepoint: First study, after study, follow up. Method of measurement: Miller Life expectancy questionnaire.;Changing the cost of treatment. Timepoint: First study, after study, follow up. Method of measurement: Miller Life expectancy questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. AA. parvizifard

Kermanshah University of Medical Sciences

Parvizia@yahoo.com+98 83 3835 8239

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026